Caiping Yao, Ph.D.

2001

Rene Levy	grad student	2001	University of Washington
(Comparison of in vitro and in vivo inhibition potencies of fluvoxamine toward CYP1A2 and CYP2C19.)

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Levy R, Ragueneau-Majlessi I, Solanki B, et al. (2008) Pharmacokinetics, safety, and tolerability of the new antiepileptic carisbamate in the elderly. Epilepsy Research. 79: 22-30
Levy RH, Hachad H, Yao C, et al. (2003) Relationship between extent of inhibition and inhibitor dose: literature evaluation based on the metabolism and transport drug interaction database. Current Drug Metabolism. 4: 371-80
Yao C, Kunze KL, Trager WF, et al. (2003) Comparison of in vitro and in vivo inhibition potencies of fluvoxamine toward CYP2C19. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 31: 565-71
Yao C, Levy RH. (2002) Inhibition-based metabolic drug-drug interactions: predictions from in vitro data. Journal of Pharmaceutical Sciences. 91: 1923-35
Yao C, Kunze KL, Kharasch ED, et al. (2001) Fluvoxamine-theophylline interaction: gap between in vitro and in vivo inhibition constants toward cytochrome P4501A2. Clinical Pharmacology and Therapeutics. 70: 415-24
Yao CP, Mather GG, Stephens JR, et al. (1999) Cytotoxicity induced by the combination of valproic acid and tumor necrosis factor-alpha: implication for valproic acid-associated hepatotoxicity syndrome. Biochemical Pharmacology. 58: 455-9